{"id":496367,"date":"2021-05-20T08:04:39","date_gmt":"2021-05-20T12:04:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/"},"modified":"2021-05-20T08:04:39","modified_gmt":"2021-05-20T12:04:39","slug":"vistagen-therapeutics-to-present-at-two-investor-conferences-in-june","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/","title":{"rendered":"VistaGen Therapeutics to Present at Two Investor Conferences in June"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., May  20, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-diPmmnybMOi-pVsMcxWSgpAo3rPHL4hFmlMx-8ouvseQsESQ7OhuJk4pPYib3TQZc4TohMj-kiRoc73cU4UFF3zlahYFvp3nquE8XLnBJ4=\" rel=\"nofollow noopener\" target=\"_blank\">VistaGen Therapeutics<\/a> (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that it will present at the following investor conferences in June:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: middle\">\n            <strong><br \/>\n              <u>Jefferies Virtual Healthcare Conference<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Wednesday, June 2<sup>nd<\/sup> at 2:30 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Webcast:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">\n            <a href=\"https:\/\/wsw.com\/webcast\/jeff174\/vtgn\/1876041\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/jeff174\/vtgn\/1876041<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Registration:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">To attend the virtual conference, please contact your Jefferies representative.<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: middle\">\n            <strong><br \/>\n              <u>William Blair 41<\/u><br \/>\n              <sup><br \/>\n                <u>st<\/u><br \/>\n              <\/sup><br \/>\n              <u> Annual Virtual Growth Stock Conference<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Thursday, June 3<sup>rd<\/sup> at 3:00 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Webcast:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">\n            <a href=\"https:\/\/wsw.com\/webcast\/blair58\/vtgn\/1959945\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/blair58\/vtgn\/1959945<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Registration:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">To attend the virtual conference, please contact your William Blair representative.<\/td>\n<\/tr>\n<\/table>\n<p>For more information regarding these investor conferences, please visit the sponsor\u2019s conference website.<\/p>\n<p>\n        <strong>About VistaGen<\/strong><br \/>\n        <br \/>VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen&#8217;s drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zYF7_oY_N9Bt0Se6zPEJHp2wISqbPmlzoPkSuHMLovfHoZIcwHocJwI6qHcbKdzwrhvgTYNbhUAWKENXqoZMEA==\" rel=\"nofollow noopener\" target=\"_blank\">www.vistagen.com<\/a> and connect with VistaGen on Twitter, LinkedIn, and Facebook.<\/p>\n<p>\n        <strong>Company Contacts<\/strong><br \/>\n        <br \/>Mark A. McPartland \/ Mark Flather<br \/>VistaGen Therapeutics, Inc.<br \/>Phone: +1 (650) 577-3600<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IR5aF4TZenetZwcu9bdVL4D24EAcGABgcSiwglaHKKK4CmMGd-LE2NkVctKGRAlviCyvuATGeJVXaRod6I9yvQ==\" rel=\"nofollow noopener\" target=\"_blank\">IR@vistagen.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/830f6732-ab1c-4059-842f-2c56fd255d3f\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that it will present at the following investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2nd at 2:30 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/jeff174\/vtgn\/1876041 Registration: To attend the virtual conference, please contact your Jefferies representative. William Blair 41 st Annual Virtual Growth Stock Conference Date: Thursday, June 3rd at 3:00 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/blair58\/vtgn\/1959945 Registration: To attend the virtual conference, please contact your William Blair representative. For more information regarding these investor conferences, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VistaGen Therapeutics to Present at Two Investor Conferences in June&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-496367","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that it will present at the following investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2nd at 2:30 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/jeff174\/vtgn\/1876041 Registration: To attend the virtual conference, please contact your Jefferies representative. William Blair 41 st Annual Virtual Growth Stock Conference Date: Thursday, June 3rd at 3:00 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/blair58\/vtgn\/1959945 Registration: To attend the virtual conference, please contact your William Blair representative. For more information regarding these investor conferences, &hellip; Continue reading &quot;VistaGen Therapeutics to Present at Two Investor Conferences in June&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T12:04:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VistaGen Therapeutics to Present at Two Investor Conferences in June\",\"datePublished\":\"2021-05-20T12:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/\",\"name\":\"VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\",\"datePublished\":\"2021-05-20T12:04:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VistaGen Therapeutics to Present at Two Investor Conferences in June\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/","og_locale":"en_US","og_type":"article","og_title":"VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that it will present at the following investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2nd at 2:30 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/jeff174\/vtgn\/1876041 Registration: To attend the virtual conference, please contact your Jefferies representative. William Blair 41 st Annual Virtual Growth Stock Conference Date: Thursday, June 3rd at 3:00 p.m. ET Webcast: https:\/\/wsw.com\/webcast\/blair58\/vtgn\/1959945 Registration: To attend the virtual conference, please contact your William Blair representative. For more information regarding these investor conferences, &hellip; Continue reading \"VistaGen Therapeutics to Present at Two Investor Conferences in June\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-20T12:04:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VistaGen Therapeutics to Present at Two Investor Conferences in June","datePublished":"2021-05-20T12:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/","name":"VistaGen Therapeutics to Present at Two Investor Conferences in June - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=","datePublished":"2021-05-20T12:04:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzOTk1MiM0MTkzNDc1IzIyMDQzODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-present-at-two-investor-conferences-in-june\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VistaGen Therapeutics to Present at Two Investor Conferences in June"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/496367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=496367"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/496367\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=496367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=496367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=496367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}